The aspartate aminotransferase‐to‐platelet ratio index (APRI), a tool with limited expense
and widespread availability, is a promising noninvasive alternative to liver biopsy for …

BACKGROUND: Liver biopsy is the reference standard for diagnosing the extent of fibrosis
in chronic liver disease; however, it is invasive, with the potential for serious complications …

The presence and degree of hepatic fibrosis is crucial in order to make therapeutic decisions
and predict clinical outcomes. Currently, the place of liver biopsy as the standard of …

Background The aspartate aminotransferase-to-platelet ratio index (APRI), a tool with limited
expense and widespread availability, is a promising noninvasive alternative to liver biopsy …

Liver fibrosis results from an excessive wound healing response in most chronic liver
diseases, such as hepatitis C. Despite great advances in antiviral therapy in recent years …

Chronic liver diseases of differing etiologies are among the leading causes of mortality and
morbidity worldwide. Establishing accurate staging of liver disease is very important for …

Significant liver fibrosis (F≥ 2) and portal hypertension (hepatic venous pressure gradient
[HVPG]≥ 6 mmHg) at 1 year after liver transplantation (LT) identify patients with severe …

Objective: Transient elastography (TE) allows non-invasive evaluation of the severity of liver
disease in patients with chronic hepatitis C. This procedure, however, warrants further …

Recurrent fibrosis after liver transplantation (LT) impacts on long-term graft and patient
survival. We performed a meta-analysis to compare the accuracy of non-invasive methods to …

Chronic liver disease (CLD) is a cause of morbidity and mortality worldwide, due to
haemodynamic and metabolic complications of liver cirrhosis. During CLD the extracellular …